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Abstract
Introduction Low central venous oxygen saturation (ScvO2) has
been associated with increased risk of postoperative
complications in high-risk surgery. Whether this association is
centre-specific or more generalisable is not known. The aim of
this study was to assess the association between peri- and
postoperative ScvO2 and outcome in high-risk surgical patients
in a multicentre setting.
Methods Three large European university hospitals (two in
Finland, one in Switzerland) participated. In 60 patients with
intra-abdominal surgery lasting more than 90 minutes, the
presence of at least two of Shoemaker's criteria, and ASA
(American Society of Anesthesiologists) class greater than 2,
ScvO2 was determined preoperatively and at two hour intervals
during the operation until 12 hours postoperatively. Hospital
length of stay (LOS) mortality, and predefined postoperative
complications were recorded.
Results The age of the patients was 72 ± 10 years (mean ±
standard deviation), and simplified acute physiology score
(SAPS II) was 32 ± 12. Hospital LOS was 10.5 (8 to 14) days,
and 28-day hospital mortality was 10.0%. Preoperative ScvO2
decreased from 77% ± 10% to 70% ± 11% (p < 0.001)
immediately after surgery and remained unchanged 12 hours
later. A total of 67 postoperative complications were recorded
in 32 patients. After multivariate analysis, mean ScvO2 value
(odds ratio [OR] 1.23 [95% confidence interval (CI) 1.01 to
1.50], p = 0.037), hospital LOS (OR 0.75 [95% CI 0.59 to
0.94], p = 0.012), and SAPS II (OR 0.90 [95% CI 0.82 to 0.99],
p = 0.029) were independently associated with postoperative
complications. The optimal value of mean ScvO2 to discriminate
between patients who did or did not develop complications was
73% (sensitivity 72%, specificity 61%).
Conclusion Low ScvO2 perioperatively is related to increased
risk of postoperative complications in high-risk surgery. This
warrants trials with goal-directed therapy using ScvO2 as a
target in high-risk surgery patients.
Introduction
Several randomised controlled clinical studies have shown
improved morbidity and mortality in high-risk surgical patients
with perioperative optimisation of haemodynamics using strict
treatment protocols in the single-centre setting [1-3]. The
haemodynamic endpoints in goal-directed studies have been
based on values derived from the pulmonary artery catheter [1-
4], oesophageal Doppler [5-10], or (very recently) lithium indi-
cator dilution and pulse power analysis [11]. Central venous
oxygen saturation (ScvO2) and mixed venous oxygen satura-
tion (SvO2) have been proposed to be indicators of the oxygen
supply/demand relationship. However, the relationship
between SvO2 and ScvO2 remains controversial [12]. Venous
oxygen saturations differ among organ systems because dif-
ferent organs extract different amounts of oxygen. It is there-
fore conceivable that venous oxygen saturation depends on
the site of measurement [13]. Redistribution of blood flow and
alterations in regional oxygen demand (for example, in shock,
severe head injury, general anaesthesia, as well as microcircu-
latory disorders) may affect the difference between ScvO2 and
SvO2. Although ScvO2 principally reflects the relationship of
oxygen supply and demand, mainly from the brain and the
upper part of the body [13], it correlates reasonably well with
concomitantly measured SvO2 [12,13], which is more
dependent on changes in oxygen extraction in the gastrointes-
tinal tract.Page 1 of 8
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HDC = high-dependency care; ICU = intensive care unit; LOS = length of stay; OR = odds ratio; ROC = receiver operator characteristic; SAPS II 
= simplified acute physiology score; ScvO2 = central venous oxygen saturation; SvO2 = mixed venous oxygen saturation.
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driven haemodynamic treatment was found to reduce mortality
[14]. More recently, low postoperative ScvO2 values were
associated with an increased risk of complications in high-risk
surgical patients [11]. Despite increasing evidence of benefi-
cial effects on outcome, goal-directed therapies are not widely
used in clinical practice. The reasons are a lack of demon-
strated effect in large multicentre studies, the need for postop-
erative intensive care resources, the necessity of instituting
complex protocols, as well as the need for monitoring tech-
niques that are not routinely used in these specific patient
groups. Using the ScvO2 as a potential target variable for
haemodynamic optimisation is attractive because central
venous catheterisation is routinely used in high-risk patients
undergoing major surgery, ScvO2 can be screened, pre-emp-
tive treatment is possible, and no major changes are neces-
sary for the infrastructure in the operation area.
The present investigation was a pilot study designed to assess
the incidence of low perioperative ScvO2 in high-risk surgical
patients and the association of low ScvO2 with outcome in a
multicentre setting. The aim was to evaluate whether the asso-
ciation of ScvO2 and postoperative complications in a strictly
protocolised, interventional single-centre study on goal-
directed haemodynamic management in high-risk surgical
patients [11] could be confirmed in a purely observational,
multicentre setting. Specifically, this pilot study was designed
to clarify (a) the recruitment rate of patients scheduled for
major surgery in a multicentre setting, (b) the range of periop-
erative ScvO2 in such patients, (c) the number of postopera-
tive complications, and (d) the potential association between
ScvO2 and complications. With these data, it should be possi-
ble to define whether a trial with goal-directed therapy using
ScvO2 as a target is reasonable to conduct.
Materials and methods
Two university hospitals in Finland and one in Switzerland par-
ticipated in the study. The study was approved by the appro-
priate ethics committee for each institution, and written
informed consent was obtained from each patient. Patients
were screened for inclusion and exclusion criteria between
September 20 and December 20, 2004.
Inclusion criteria
For a patient to be included in the study, both of the following
criteria had to be fulfilled: (a) increased surgical risk based on
intra-abdominal or retroperitoneal surgery with an expected
duration of at least 90 minutes or on abdominal aortic surgery
and (b) two or more of Shoemaker's criteria of high risk [2].
These criteria include patient history (more than 70 years old
with limited major physiological function, previous severe car-
diopulmonary or vascular illness, and severe nutritional disor-
ders), current clinical condition (severe multiple trauma,
massive acute blood loss, shock, septicaemia or septic shock,
respiratory failure, acute abdominal catastrophe, and acute
intestinal or renal failure), the surgical procedure (extensive
surgery for cancer or prolonged surgery more than eight
hours), ASA (American Society of Anesthesiologists) class of
greater than two, and a perioperative need for a central venous
catheter.
Exclusion criteria
Exclusion criteria for the study were a contraindication for a
central venous catheter, unstable angina pectoris, primary
hepatic or hepato-biliary surgery, the refusal of blood prod-
ucts, and the inability to give informed consent or refusal to
consent.
Study protocol
Anaesthesia, operation, and postoperative treatment were
performed according to the local standards. All patients were
postoperatively admitted either to an intensive care unit (ICU)
or another high-dependency care (HDC) area (intermediate
care unit or postanaesthesia care unit). Blood samples for the
measurement of ScvO2 and haemoglobin were taken after
induction of anaesthesia and thereafter at two hour intervals
up to 12 hours postoperatively. Blood gas analyses were per-
formed by intermittent blood sampling and co-oximetry (ABL
725; Radiometer, Copenhagen, Denmark [centres 1 and 2];
GEM Premier 3000; Instrumentation Laboratory, Barcelona,
Spain [centre 3]).
Complications
Complications and deaths occurring within 28 days of enrol-
ment were included in the data analysis. Complications were
prospectively defined and were diagnosed by clinical staff.
Length of stay in the study hospital was censored at 28 days,
and the patient's location at 28 days was recorded.
Statistics
Data are presented as mean ± standard deviation when nor-
mally distributed, as medians (interquartile range) when not
normally distributed, or (for categorical variables) as a percent-
age of the group from which they were derived. Normality was
tested with the Kolmogorov-Smirnov test. Categorical data
were tested with Fisher's exact test. Continuous data were
tested with the t test when normally distributed and with the
Mann-Whitney U test when not normally distributed. Trends in
physiological parameters over time were compared with
repeated-measures analysis of variance.
Univariate analysis was performed to test associations with
complications and death. For data recorded hourly during the
study period, the baseline values, the lowest values, and the
mean over the 12-hour study period were tested. A multiple
logistic regression model was used to identify independent
risk factors for postoperative complications. A stepwise
approach was used to enter new terms into the logistic regres-
sion model, where p < 0.05 was set as the limit for inclusion
of new terms. Results of logistic regression are reported asPage 2 of 8
(page number not for citation purposes)
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(CIs). Receiver operator characteristic (ROC) curves were
constructed to identify optimal cutoff values for association
with outcome. The optimum cutoff was defined as the value
associated with the highest sum of sensitivity and specificity.
Analysis was performed with SPSS version 12.01 (SPSS Inc.,
Chicago, IL, USA) and Sigma Plot version 10.01 (Systat Soft-
ware, Inc., Richmond, CA, USA) software, and significance
was set at p < 0.05.
Results
Of 218 screened patients, 60 patients fulfilled requirements
for both inclusion and exclusion criteria and gave written
informed consent (21 females, 39 males). Their mean age was
72 ± 10 years, and simplified acute physiology score (SAPS
II) was 32 ± 12. In two centres, all patients were elective sur-
gical cases, whereas in the third centre, 12 out of 21 patients
were emergencies. Demographics and outcome data as well
as indications for laparatomy stratified for the three centres are
indicated in Table 1. Mean SAPS II scores in the three centres
were 30, 26, and 40, respectively, and the associated mortal-
ity rates were 0%, 6%, and 24%, respectively.
As compared with preoperative values, ScvO2 was lower
immediately after surgery. Haemoglobin decreased (preopera-
tive 110 ± 19 g/l versus 102 ± 17 g/l immediately after sur-
gery, p = 0.003).
Overall length of stay in the ICU/HDC was 1.0 (0 to 1) days,
and hospital LOS was 10.5 (8 to 14) days (observation period
28 days). Six patients died (28-day mortality 10%); three of
them were emergency cases (28-day mortality in emergency
cases 25%).
Sixty-seven postoperative complications were recorded in 32
patients (20 cardiorespiratory, 23 surgical, 19 infectious, and
5 other; between 1.0 and 1.3 per patient per centre). Univari-
ate analysis identified nine variables associated with postoper-
ative complications (Table 2). Six of them were ScvO2
variables (Figure 1a,b). Additionally, haemoglobin (111 ± 18
versus 105 ± 23 g/l, p = 0.018), SAPS II (27 ± 11 versus 45
± 26, p = 0.003), and hospital LOS (10 [8 to 12] versus 14
[10 to 17] days, p = 0.001) were associated with postopera-
tive complications.
After multivariate analysis, mean ScvO2 value (OR 1.23 [95%
CI 1.01 to 1.50], p = 0.037), hospital LOS (OR 0.75 [95% CI
0.59 to 0.94], p = 0.012), and SAPS II (OR 0.90 [95% CI
0.82 to 0.99], p = 0.029) were independently associated with
postoperative complications. ROC curves for these variables
are displayed in Figure 2. The areas under the ScvO2 and
SAPS II, but not LOS, ROC curves were significantly different
from 0.5 (p = 0.004 and 0.002, respectively). The optimal
value of mean ScvO2 for discriminating between patients who
did or did not develop complications was 73% (sensitivity
Table 1
Demographics and outcome data stratified for the three centres
All centres (n = 60) Centre 1 (n = 17) Centre 2 (n = 22) Centre 3 (n = 21)
Age in years 72 ± 10 68 ± 11 72 ± 9 74 ± 10
Male/female 40/20 13/4 18/4 16/5
SAPS IIa 32 ± 12 26 ± 10 30 ± 4 40 ± 14
Emergency surgery (percentage) 20 0 0 57
Aortic/iliacal aneurysm/dissection (percentage) 47 82 50 14
Carcinoma upper abdomen (percentage) 12 12 5 5
Carcinoma lower abdomen (percentage) 24 6 41 38
Infection (percentage) 7 0 4 19
Other (percentage) 10 0 0 24
Duration of operation (minutes) 218 ± 111 323 ± 92 178 ± 81 177 ± 99
Hospital LOS (days) 11 (8 to 14) 13 (11 to 15) 8 (4 to 10) 11 (9 to 14)
Patients at home on day 28 (percentage) 65 23 90 38
Patients in hospital/nursing facility on day 28 (percentage) 22 65 5 38
Unknown patient location on day 28 (percentage) 3 6 5 0
Mortality (percentage) 10 6 0 24
aOne-way analysis of variance (p < 0.01). LOS, length of stay; SAPS II, simplified acute physiology score.Page 3 of 8
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pital LOS in survivors and non-survivors is displayed in Figure
3.
Discussion
The main finding of this study was that in the multicentre set-
ting, low ScvO2 during the peri- and postoperative period was
associated with an increased risk of postoperative complica-
tions in high-risk patients undergoing major surgery. Our
results support the feasibility of testing ScvO2 as a target var-
iable to improve outcome in high-risk surgery. The criteria to
define patients at high risk were pragmatic and clinically ori-
ented and resulted in a sufficient recruitment rate. Further-
more, despite the relative heterogeneity of the patient
population, ScvO2 had a reasonable predictive value for post-
operative complications.
Pearse et al. [11] found that low minimum ScvO2 values during
the first eight postoperative hours were associated with
increased risk of postoperative complications. Their findings
Table 2
Variables associated with postoperative complications
Patients with complications (n = 32) Patients without complications (n = 28) P valuea
ScvO2 (percentage)
Preoperative 74 ± 10 80 ± 9 0.031
Intraoperative
After 1 hour of surgery 74 ± 10 80 ± 9 0.046
After 2 hours of surgery 73 ± 12 80 ± 11 0.022
After 3 hours of surgery 71 ± 11 81 ± 8 0.001
Lowest 60 ± 7 64 ± 7 0.036
Mean 70 ± 5 74 ± 6 0.005
Haemoglobin at ICU admission (g/l) 95 ± 17 105 ± 13 0.018
SAPS II 41 ± 14 27 ± 11 0.003
Hospital LOS (days) 13 ± 7 10 ± 4 0.001
aUnivariate analysis of variance. ICU, intensive care unit; LOS, length of stay; SAPS II, simplified acute physiology score; ScvO2, central venous 
oxygen saturation.
Figure 1
Intraoperative (a) and postoperative (b) ScvO2 variables in patients who did and did not develop postoperative complicationsi l  i li i . P values correspond 
to univariate analysis of variance. ICU, intensive care unit; IMC, intermediate care unit; intraop, intraoperative; preop, preoperative; postop, postoper-
ative; ScvO2, central venous oxygen saturation.Page 4 of 8
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Receiver operator characteristic (ROC) analysis for (a) mean ScvO2, (b) SAPS II score, and (c) hospital length of stay (LOS). Outcome parameter 
for ROC analysis is occurrence of postoperative complications. Area under the curve (AUC) was 0.74 for mean ScvO2 (p = 0.004), 0.78 for SAPS 
II score (p = 0.002), and 0.61 for LOS (p = 0.15). SAPS II, simplified acute physiology score; ScvO2, central venous oxygen saturation.
Figure 3
Central venous oxygen saturation (ScvO2) (percentage) in survivors and non-survivors and in patients with high and low mean ScvO2 values. The 
numbers above the error bars indicate the corresponding LOS data for the different sub-groups. *Wilcoxon signed rank test versus preoperative (p 
< 0.05). #Mann-Whitney test versus ScvO2 >73% (p = 0.001). ICU/IMC, intensive care unit/intermediate care unit; LOS, length of stay in hospital.Page 5 of 8
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study on goal-directed haemodynamic management in high-
risk surgical patients. Our results further confirm the associa-
tion between ScvO2 and postoperative complications in a
purely observational, multicentre setting. Furthermore, intraop-
eratively, we were able to demonstrate a significant difference
in ScvO2 between patients who did and did not develop com-
plications. Taken together, the present study and that of
Pearse et al. suggest that the overall peri- and postoperative
course of ScvO2 should be taken into account if ScvO2-tar-
geted interventions are considered for testing in large-scale
clinical trials.
Despite the relative similarity of the participating centres and
the presence of comparable infrastructures for postoperative
care, the hospital LOS varied widely between the centres. The
reason for this is certainly multifactorial and likely to include,
among other things, care processes within the individual cen-
tres, discharge policies, and variations in local health care
organisation. These variations were likely to dilute any associ-
ation between ScvO2 and length of stay in the relatively small
sample size. Hence, we used clinically relevant predefined
complications as the main outcome measure. The hospital
mortality in the present study was comparable with the recent
study of Pearse et al. [11] and clearly lower than what would
be expected from several previous studies on high-risk sur-
gery. Due to the small sample size and different proportions of
emergency patients, relevant between-centre comparisons
cannot be made.
The prognostic significance of ScvO2 less than 65% has been
demonstrated in myocardial infarction [15], trauma [16],
severe sepsis [17], and cardiac failure [18]. However, the only
interventional trial of ScvO2 conducted so far used a target of
70% [14]. In the study of Pearse et al. [11], a level of 65%
seemed to discriminate best between patients with and
without complications. This may be related to the lower tissue
oxygen delivery in surgical patients as compared with patients
with sepsis. Despite complex physiology, the association
between ScvO2 and outcome after major surgery seems to be
similar to the association between cardiac index and outcome
or between oxygen delivery and outcome [19-22].
The best cutoff for ScvO2 in predicting complications in our
study was 73%. This corresponds well with the mean ScvO2
of 75% found by Pearse et al. [11] in patients who did not
develop complications. The observed cutoff value of ScvO2
should be interpreted with some caution due to the sample
size. Nevertheless, the somewhat higher best cutoff of ScvO2
for predicting complications in our study could be related to
the fact that our study was observational, whereas Pearse et
al. used protocolised treatment. When using protocols, the
fluctuation in ScvO2 is likely to be reduced. This may also
explain why in our study the mean ScvO2, rather than the min-
imum ScvO2, had predictive value.
In our study, the perioperative mean of ScvO2 was 74% in
patients who did not develop postoperative complications.
This is comparable with previous measurements in healthy
subjects [23] and in patients after surgery [11,22] but is
higher than in patients with favourable outcome after severe
sepsis, trauma, cardiac failure, or myocardial infarction [15-
18]. Accordingly, targets for ScvO2 in future prospective trials
should probably be adapted to the specific study groups.
We believe that our results encourage trials with goal-directed
therapy using ScvO2 as a target in high-risk surgery patients.
Based on our data and in agreement with results from others
[11], target values should be in the range of 70% to 75%, and
values less than 65% should be strictly avoided. In patients
with cardiac failure or trauma, lower targets (at approximately
65%) may be appropriate [15,16].
Obviously, in a multicentre approach, the inclusion of 60
patients with an observed 28-day mortality of 10% is enough
to be able to demonstrate a benefit in terms of complication
rate but not in terms of length of stay and mortality. To demon-
strate a relative reduction in 28-day mortality of 34% (as in the
study of Rivers et al. [14], with a beta error of 80% and an
alpha error of 5%, the sample size in a patient group similar to
that in this study would be 85 for both groups. Although the
risk factors for postoperative complications agree well with
previous studies, the small sample size for the multivariate
analysis should be considered in interpreting our results.
Because oxygen demands are normally well controlled during
general anaesthesia, efforts to increase ScvO2 should target
oxygen delivery (arterial oxygen saturation, haemoglobin, and
cardiac output). In fact, in this trial, preoperative haemoglobin
concentrations were significantly lower in patients with com-
plications as compared with patients without. To avoid sudden
drops in ScvO2 as a consequence of the combination of hypo-
volaemia and anaemia during surgical bleeding, it may be pru-
dent to correct low (<10 g/dl) preoperative haemoglobin
concentrations.
A drop in ScvO2 was noted between the end of surgery and
the first readings in the ICU. This finding is consistent with pre-
vious findings on ScvO2 [11] and SvO2 [19,21] in surgical
patients. Both decreased systemic oxygen delivery and
increased oxygen consumption may have contributed. Pearse
et al. [11] reported unchanged cardiac output in the postoper-
ative period. If this was the same in our patients, oxygen deliv-
ery still could have decreased due to the significantly lower
postoperative haemoglobin concentrations. Postoperative
oxygen consumption is determined by various factors, includ-
ing pain, emergence from anaesthesia, body temperature, and
shivering. To avoid low postoperative ScvO2, all of these fac-
tors may have to be controlled.Page 6 of 8
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In our study, low ScvO2 was frequently observed in patients
during and after major surgery and was related to postopera-
tive complications. In prospective trials using ScvO2 as a goal,
the specific patient group has to be taken into account when
target levels are defined.
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